4.05 USD
+0.04 (+1%)
PHGE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While PHGE seems to be doing ok healthwise, there are quite some concerns on its profitability. PHGE has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- PHGE had negative earnings in the past year.
- PHGE had a negative operating cash flow in the past year.
- PHGE had negative earnings in each of the past 5 years.
- In the past 5 years PHGE always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -48.80%, PHGE is in line with its industry, outperforming 52.00% of the companies in the same industry.
- PHGE has a Return On Equity (-96.91%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.8% | ||
| ROE | -96.91% | ||
| ROIC | N/A |
ROA(3y)-69.25%
ROA(5y)-59.4%
ROE(3y)-352.46%
ROE(5y)-237.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PHGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- PHGE has less shares outstanding than it did 1 year ago.
- PHGE has less shares outstanding than it did 5 years ago.
- PHGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- PHGE has an Altman-Z score of -9.68. This is a bad value and indicates that PHGE is not financially healthy and even has some risk of bankruptcy.
- PHGE's Altman-Z score of -9.68 is on the low side compared to the rest of the industry. PHGE is outperformed by 71.43% of its industry peers.
- There is no outstanding debt for PHGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.68 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- PHGE has a Current Ratio of 2.66. This indicates that PHGE is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.66, PHGE is doing worse than 68.95% of the companies in the same industry.
- A Quick Ratio of 2.66 indicates that PHGE has no problem at all paying its short term obligations.
- With a Quick ratio value of 2.66, PHGE is not doing good in the industry: 67.05% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.66 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
- PHGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.62%, which is quite impressive.
EPS 1Y (TTM)43.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- PHGE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.00% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-834.26%
EPS Next 2Y-95.21%
EPS Next 3Y-33.04%
EPS Next 5Y12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- PHGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year PHGE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as PHGE's earnings are expected to decrease with -33.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-95.21%
EPS Next 3Y-33.04%
5. Dividend
5.1 Amount
- No dividends for PHGE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIOMX INC / PHGE FAQ
What is the fundamental rating for PHGE stock?
ChartMill assigns a fundamental rating of 2 / 10 to PHGE.
What is the valuation status of BIOMX INC (PHGE) stock?
ChartMill assigns a valuation rating of 0 / 10 to BIOMX INC (PHGE). This can be considered as Overvalued.
How profitable is BIOMX INC (PHGE) stock?
BIOMX INC (PHGE) has a profitability rating of 1 / 10.
Can you provide the financial health for PHGE stock?
The financial health rating of BIOMX INC (PHGE) is 6 / 10.